Radiation doses from (161)Tb and (177)Lu in single tumour cells and micrometastases

BACKGROUND: Targeted radionuclide therapy (TRT) is gaining importance. For TRT to be also used as adjuvant therapy or for treating minimal residual disease, there is a need to increase the radiation dose to small tumours. The aim of this in silico study was to compare the performances of (161)Tb (a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcocer-Ávila, Mario E., Ferreira, Aymeric, Quinto, Michele A., Morgat, Clément, Hindié, Elif, Champion, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237560/
https://www.ncbi.nlm.nih.gov/pubmed/32430671
http://dx.doi.org/10.1186/s40658-020-00301-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237560/
https://www.ncbi.nlm.nih.gov/pubmed/32430671
http://dx.doi.org/10.1186/s40658-020-00301-2

Ejemplares similares